Fate Therapeutics (FATE) Cash & Current Investments (2012 - 2026)
Fate Therapeutics (FATE) reported Cash & Current Investments of $153.8 million for Q2 2026, down 31.0% from $222.83 million a year earlier and down 12.0% from the prior quarter.
Fate Therapeutics (FATE) Cash & Current Investments (2012 - 2026) Analysis & Trends
At the end of FY2025, Fate Therapeutics posted Cash & Current Investments of $203.66 million, down 27.0% from FY2024.
- Cash & Current Investments has declined for four consecutive years, with a five-year compound annual growth rate of -15.9% (FY2020 to FY2025).
- By year, Cash & Current Investments came in at $279.07 million in FY2024 (-11.5%), $315.18 million in FY2023 (-27.7%), $436.23 million in FY2022 (-29.2%) and $615.91 million in FY2021 (+27.5%).
- The Q2 2026 figure ranks as the lowest quarterly Cash & Current Investments since Q2 2018.
- Year over year, Cash & Current Investments has now declined in each of the last 18 quarters, with an average decline of 25.4% over the last eight quarters.
- The high point for year-over-year Cash & Current Investments in five years was Q3 2021 (growth of 38.8%); the low point was Q1 2025 (a decline of 37.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $174.8 million (Q1 2026), $203.66 million (Q4 2025) and $215.42 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Fate Therapeutics | 255.84 Mn | 102.04 Mn | - | 153.80 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 153.80 Mn |
| Mar 31, 2026 | 174.80 Mn |
| Dec 31, 2025 | 203.66 Mn |
| Sep 30, 2025 | 215.42 Mn |
| Jun 30, 2025 | 222.83 Mn |
| Mar 31, 2025 | 240.43 Mn |
| Dec 31, 2024 | 279.07 Mn |
| Sep 30, 2024 | 296.92 Mn |
| Jun 30, 2024 | 304.88 Mn |
| Mar 31, 2024 | 383.54 Mn |
| Dec 31, 2023 | 315.18 Mn |
| Sep 30, 2023 | 349.73 Mn |
| Jun 30, 2023 | 377.94 Mn |
| Mar 31, 2023 | 408.90 Mn |
| Dec 31, 2022 | 436.23 Mn |
| Sep 30, 2022 | 505.14 Mn |
| Jun 30, 2022 | 568.85 Mn |
| Mar 31, 2022 | 573.77 Mn |
| Dec 31, 2021 | 615.91 Mn |
| Sep 30, 2021 | 678.70 Mn |
Fate Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=FATE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "FATE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=FATE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();